Classifications

• • G—PHYSICS
  • G02—OPTICS
  • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
  • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
  • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
  • G02B1/041—Lenses
  • G02B1/043—Contact lenses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
  • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
  • A61L27/14—Macromolecular materials
  • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
  • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
  • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
  • A61L2430/00—Materials or treatment for tissue regeneration
  • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Definitions

• Intraocular lenses essentially free from glistenings
• the present invention relates to intraocular lenses manufactured from copolymers comprising a single high refractive index monomer, wherein the intraocular lenses are essentially free from glistenings.
• IOL intraocular lenses
• Materials that are commonly used for such lenses include hydrogels, silicones and acrylic polymers.
• Hydrogels have a relatively low refractive index which makes them less desirable materials because of the thicker lens optic that is necessary to achieve a given refractive power.
• Silicones have a higher refractive index than hydrogels, but tend to unfold explosively after being placed in the eye in a folded position. Explosive unfolding can potentially damage the corneal endothelium and/or rupture the natural lens capsule.
• Acrylic polymers are currently the material of choice since they typically have a high refractive index and unfold more slowly or controllably than silicone materials.
• US 5.290.892 and US 5.331.073 disclose high refractive index, acrylic copolymers suitable for use as an IOL material.
• IOL material A further requirement for IOL material is that rolling the lens does not induce tears or wrinkles so that after release of the lens from the cartridge nozzle the lens unfolds in a controlled way to its pre-rolled dimensions without its optical quality being compromised.
• the material must also be stiff enough such that thin high refractive index lenses do not deform when residing in the eye. After all, lenses must remain flat to retain their optical properties.
• a known method for manufacturing IOL's comprises polymerization of the acrylic monomer composition in open moulds where after the raw IOL is further mechanically processed by lathing, drilling, grinding and the like.
• Such methods wherein in particular closed castmoulds are employed might give rise to the formation of vacuoles filled with air or gas in the polymerised material.
• Such vacuoles are in particular formed when thermal free radical initiators such as azo initiators are used that form gases as byproducts.
• vacuoles Upon implantation of the IOL, these vacuoles are hydrated thereby giving rise to the formation of white dots due to reflection of light, a phenomenon known in the art as "glistenings". In fact, these vacuoles containing moisture have a refractive index that is different from that of the IOL material.
• a solution for this problem that is provided by the prior art is employing an acrylate monomer composition comprising at least one hydrophobic, high refractive index IOL-forming monomer in conjunction with a small amount of a hydrophilic monomer. By the incorporation of the latter, the hydrophilicity of the IOL is improved so that any moisture is better dispersed within the IOL.
• US 5.693.095 discloses acrylic monomer compositions comprising a hydrophilic monomer, e.g. 2-hydroxyethyl acrylate, and a high refractive index, IOL- forming, hydrophobic aryl acrylic monomer having the general formula:
• H 2 C C C O (CH 2 ) m Y Ar
• the acrylic monomer compositions further comprise a crosslinker such as 1,4-butanediol diacrylate.
• the polymerization of the acrylic monomer composition is preferably thermally initiated by using peroxy free radical initiators.
• the polymerized materials are said to be substantially free of glistenings.
• US 6.140.438 and US 6.326.448 disclose an acrylic monomer composition comprising an aromatic ring containing (meth)acrylate monomer (A) of the formula:
• Ri is hydrogen or methyl
• n is an integer of 0 - 5
• X is a direct bond or oxygen
• R 2 is an optionally substituted aromatic group
• a hydrophilic monomer (B) an alkyl(meth)acrylate monomer (C) wherein the alkyl group has 1 - 20 carbon atoms
• a crosslinker (D) The polymerization can be conducted by any conventional method, i.e. thermally by using azo or peroxide initiators or by irradiation with electromagnetic waves such as UV.
• the polymerized material has a water absorptivity of 1.5 to 4.5 wt.% and has an improved transparency.
• the polymerized materials are further mechanically processed into IOL's.
• US 6.329.485 and US 6.657.032 disclose an acrylic monomer composition
• a high refractive index aromatic acrylate monomer a hydrophilic monomer in an amount higher than that of the high refractive index aromatic acrylate monomer, and a crosslmker.
• the polymerization is preferably conducted by thermal initiation in the presence of azo or peroxide initiators, preferably the azo initiator 2,2'- azobis(isobutyronitril). After polymerization, the polymerized materials are further mechanically processed as described above to form IOL's.
• A is hydrogen or methyl
• B is -(CH 2 ) m - wherein m is an integer of 2 - 5
• Y is a direct bond or oxygen
• C is -(CH 2 )W- wherein w is an integer of 0 or 1
• Ar is phenyl.
• the IOL material is made from these monomers only and a cross-linking monomer.
• the refractive index is at least 1.50
• de glass transition temperature is preferably below 25°C and the elongation is at least 150 %.
• US 2005/0049376 discloses curable (meth)acrylate compositions suitable for optical articles and in particular for light management films. Apart from a high refractive index, these compositions when cured have desirably a high glass transition temperature for shape retention during storage and use of the light management films. Tables 7 and 8 disclose glass transition temperatures of 41° - 62°C.
• the refractive index of a composition made of l,3-bis(thiophenyl)propane-2-yl acrylate and the diacrylate of tetrabromo bisphenol A diepoxide has a refractive index as high as 1.6016 (Example 14). Although generally having a high refractive index, the compositions are obviously unsuitable for IOL applications because of their high glass transition temperatures.
• US 6.015.842 discloses a method for preparing a foldable, acrylic, high refractive index ophthalmic material from a composition comprising a hydrophilic crosslinker, e.g. polyethyleneoxide di(meth)acrylate, one or more hydrophilic monomers, a UV absorbing chromophore and a benzoyl phosphine oxide photoinitiator which can be activated by blue light having a wave length in the range of 400 - 500 nm.
• a hydrophilic crosslinker e.g. polyethyleneoxide di(meth)acrylate
• one or more hydrophilic monomers e.g. polyethyleneoxide di(meth)acrylate
• a UV absorbing chromophore e.g., a UV absorbing chromophore
• a benzoyl phosphine oxide photoinitiator which can be activated by blue light having a wave length in the range of 400 - 500 nm.
• US 2005/0055090 discloses an intraocular lens that is made from a high refractive index monomer, a photoinitiator that can be activated by blue light having a wave length of above 500 nm.
• the high refractive index monomer is for example 2- ethylphenoxy (meth)acrylate and 2-ethylthiophenyl (meth)acrylate. It is therefore an object of the invention to provide a method for manufacturing
• IOL' s having a high refractive index as well as a low glass transition temperature, in particular a glass transition temperature of lower than 25°C. It is a further object of the invention to provide a method for manufacturing IOL's that are essentially free from glistenings.
• the present invention relates to a method for manufacturing an intraocular lens, wherein an acrylic monomer composition containing a single high refractive index monomer according to formula (I):
• R 1 is H or CH 3 ;
• R 2 is a Ci - C 3 alkylene or -Ci-C 3 alkylene)-Y-(Ci-C 3 alkylene)-;
• Y is O or S;
• R 3 is Ce - Ci 8 aryl or heteroaryl;
• the present invention also relates to an intraocular lens that is obtainable according the method of the invention. Detailed description of the invention
• the method according to the invention can conveniently be performed in a closed castmould and provides ready-to-use IOL's, i.e. that minimal (e.g. only cutting) or no further mechanical processing is necessary.
• the IOL's formed by the method according to the present invention are essentially free from glistenings.
• a test for evaluating the presence of glistenings is disclosed in US 5.693.095, incorporated by reference for the US patent practice. According to the present invention, the following definitions apply.
• alkyl groups examples include methyl, ethyl, 1 -propyl, 2- propyl, 1 -butyl, 2-butyl, 1-pentyl, 1 -hexyl and the like.
• An alkylene group is to be understood as a linear or branched alkylene group having 1 to 3 carbon atoms, e.g. 1,3-propanediyl (-CH 2 -CH 2 -CH 2 -) and ethanediyl (-CH 2 -CH 2 -).
• An aryl group is to be understood as an aryl group having 6 to 18 carbon atoms.
• the aryl group may be substituted or unsubstituted. If the aryl group is substituted, it is preferred that they aryl group is substituted with 1 to 5 substituents, preferably 1 to 3 substituents, selected from the group consisting of halo, C1-C4 alkyl, C1-C4 alkyl-O-, Ci-C 4 alkyl-S-, Ci-C 4 haloalkyl, Ci-C 4 haloalkyl-O- and Ci-C 4 haloalkyl-S-.
• the aryl group may also be an annelated aryl group such as naphtyl and anthracenyl.
• a heteroaryl group is to be understood as an aryl group having 6 to 18 carbon atoms and comprising one to three, preferably one to two heteroatoms selected from the group consisting of nitrogen, oxygen and sulphur.
• Suitable examples of heteroaryl groups include imidazolyl, furanyl, isoxazolyl, pyranyl, pyrazinyl, pyrazolyl, pyridyl and the like.
• the heteroaryl group may also be an annelated heteroaryl group such as indolyl and benzothiazolyl.
• Y is S.
• R 4 is substituted, it is preferably substituted by C1-C4 alkyl, C1-C4 alkyl-O- or C1-C4 alkyl-S-. However, R4 is most preferably unsubstituted and is most preferably phenyl.
• (I) are know to the person skilled in the art and include for example chromatography and treatment with active carbon.
• the initiator is selected from the group of thermal free radical initiators like peroxides or azo-initiators like 2,2'-Azobis(2,4-dimethylvaleronitrile).
• the initiator is selected from the group consisting of phosphine oxide photoinitiators, ketone-based photoinitiators and benzoin photoinitiators since those initiators do not give rise to the formation of gaseous byproducts.
• the initiator is a phosphine oxide photoinitiator.
• phosphine oxide photoinitiators include the IRGACURE ® and DAROCURETM series of phosphine oxide initiators available from Ciba Specialty Chemicals, the LUCIRIN ® series available from BASF and the ESACURE ® series.
• the photoinitiators employed in the method according to the present invention can be activated by irradiation with light having a wavelength of 340 nm or more, preferably 390 nm or more. Even more preferred is that the light has a wave length of 390 nm to 500 nm (UV/VIS-irradiation; this particular region is also known in the art as "blue-light irradiation").
• Ketone-based photoinitiators and benzoin photo initiators are preferably used in combination with light having a wave length of 340 nm or more, preferably a wave length of 340 - 500 nm.
• the acrylic monomer composition comprises a crosslinker, preferably selected from the group consisting of terminally ethylenically unsaturated compounds having more than one unsaturated group, preferably a (meth)acrylate group.
• Suitable cross-linking monomers according to this fourth preferred embodiment of the present invention include: ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; allyl methacrylate; 2,3-propanediol dimethacrylate; and 1,4-butanediol dimethacrylate.
• crosslinker is in particular preferred in that water and moisture are better retained thereby reducing glistening.
• a hydrophilic monomer such as hydroxylethyl acrylate may be used as well in combination with the single high refractive index monomer.
• the crosslinker is a multifunctional (meth)acrylate monomer which comprises at least two (meth)acrylate moieties.
• the crosslinker is represented by the general formula (II):
• R 1 is H or CH 3 ;
• R 7 is substituted or unsubstituted C1-C300 alkyl, aryl, alkaryl, arylalkyl or heteroaryl;
• the substituents of R 7 are preferably selected from the group consisting of halo, Ci-C 4 alkyl, Ci-C 4 haloalkyl, Ci-C 4 alkyl-O-. Ci-C 4 alkyl-S-, Ci-C 4 haloalkyl-O-, Ci-C 4 haloalkyl-S- and OH-.
• Suitable examples of crosslinkers according to this preferred embodiment are e.g. disclosed in US 6.653.422 which is incorporated by reference for the US patent practice.
• the cross- linking monomer is a dendritic, star or hyperbranched (co)polymer having terminal OH end groups that are partly or completely esterified with (meth)acrylic acid.
• the crosslinker is a hydrophilic crosslinker. This third preferred embodiment is preferred over the first and second preferred embodiments.
• the hydrophilic crosslinker according to the third preferred embodiment has the formula (III):
• R 1 and R 5 are independently H or CH 3 ; and o is such that the number-average molecular weight is about 200 to about 2000. However, according to the invention it is most preferred that o is 1 - 5.
• R 1 is CH 3 . It is also preferred that R 5 is H.
• the acrylic monomer composition may comprise the high refractive index monomer according to formula (I) and the crosslmker in various amounts which is inter alia dependent from the desired product properties, e.g. glass transition temperature, mechanical properties such as elongation.
• the acrylate monomer composition comprises at least 50 wt. % of high refractive index monomer according to formula (I), preferably at least 60 wt.
• the upper limit for the high refractive index monomer according to formula (I) is 99.8 wt. % .
• the acrylic monomer composition will further comprise the crosslmker in an amount of 0.1 to 20.0 wt.%, preferably 0.5 to 15.0 wt.%, based on the total weight of the acrylate monomer composition.
• the acrylate monomer composition can be polymerised directly in a mould, preferably a closed castmould.
• a mould preferably a closed castmould.
• prepolymerise the acrylate monomer composition and to finalise curing of the prepolymerised acrylate monomer composition in the mould, preferably a closed castmould.
• the polymer composition according to the present invention may contain a total of up to about 10% by weight of additional components, based on the total weight of the monomer mixture, which serve other purposes, such as UV absorbers.
• Suitable UV absorbers include benzotriazole compounds such as the Tinuvin series.
• An example is 2-(2'-hydroxy-3'- methallyl-5'-methylphenyl)benzotriazole (Tinuvin P).
• UV absorber is present in an amount of 0.1 to 5.0 wt.%, preferably 0.2 to 4.0 wt.%, based on the total weight of the acrylate monomer composition.
• the present invention also relates to an intraocular lens, preferably a flexible intraocular lens, obtainable by the method according to the invention.
• the intraocular lens has a glass transition temperature T g of less than 25°C, preferably less than 15°C, more preferably less than 10 0 C, which can be attained by using the hydrophobic high refractive index monomer according to formula (I).
• the IOL has a refractive index of at least 1.50, preferably at least 1.55 and more preferably at least 1.60.
• the intraocular lens has excellent mechanical properties, e.g. an elongation of at least 150%, preferably at least 200% and more preferably at least 300%.
• a suitable method for measuring elongation is for example disclosed in US 6.653.422, incorporated by reference herein for the US patent practice.
• the HRI Monomers were synthesized as described below. Their purity was typically 95+%. Other ingredients were purchased off the shelf from outside vendors. Typically 99+% quality materials were used. Synthesis was performed in suitable laboratory glassware. Blue light irradiations for curing were performed using a suitable blue light source under a suitable atmosphere at RT (Room Temperature).
• Alcohol l,3-bis(phenylthio)propan-2-ol (20.0 g, 72.46 mmol, 1.0 eq) was dissolved in THF (400 mL), under nitrogen atmosphere. Et 3 N (17.3 mL, 123.2 mmol, 1.7 eq) and a few crystals of 4-methoxyphenol were added. Methacrylolylchloride (10.6 mL, 108.7 mmol, 1.5 eq) (freshly distilled) was added. The solution was warmed to 50°C and stirred for 48 h. The mixture was concentrated in vacuo and dichloromethane (300 mL) was added. The mixture was poured in cold sat. aq. NH4CI sol.
• the HRI monomer l,3-bis(phenylthio)propan-2-yl methacrylate (M2) was formulated in the following composition under subdued light conditions to avoid premature decomposition of the photoinitiator:
• the photocurable HRI monomer containing composition as prepared previously was added to a polymeric castmould consisting of a lower and a upper half enclosing a space in the form of an IOL moulding.
• the mould was irradiated with blue light under suitable conditions for the appropriate amount of time. After opening of the mould the IOL moulding was removed and inspected for quality. It was found that the moulding consisted of an optically transparent material with the desired properties for a suitable IOL material. The moulding did not tear on folding, and returned to the original dimensions when the folding force was released. Folding marks were not visible after folding, while elongation was about 100%.

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Physics & Mathematics (AREA)
• Public Health (AREA)
• Epidemiology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Veterinary Medicine (AREA)
• Dermatology (AREA)
• Transplantation (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Physics & Mathematics (AREA)
• Optics & Photonics (AREA)
• Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
• Materials For Medical Uses (AREA)
• Prostheses (AREA)
• Polymers & Plastics (AREA)
• Organic Chemistry (AREA)

Priority Applications (5)

Applications Claiming Priority (4)

Related Child Applications (1)

Publications (1)

Family

ID=36603681

Family Applications (1)

Country Status (7)

Cited By (2)

Families Citing this family (16)

Citations (4)

Family Cites Families (17)

• 2006
  • 2006-02-14 EP EP06101664A patent/EP1818690A1/en not_active Withdrawn
• 2007
  • 2007-02-14 CN CN 200780008412 patent/CN101401012A/zh active Pending
  • 2007-02-14 JP JP2008554167A patent/JP2009526561A/ja active Pending
  • 2007-02-14 US US12/279,290 patent/US9103964B2/en not_active Expired - Fee Related
  • 2007-02-14 CN CN 201110143888 patent/CN102250282B/zh not_active Expired - Fee Related
  • 2007-02-14 EP EP07715879A patent/EP1984761B1/en not_active Expired - Fee Related
  • 2007-02-14 DE DE602007013360T patent/DE602007013360D1/de active Active
  • 2007-02-14 ES ES07715879T patent/ES2362134T3/es active Active
  • 2007-02-14 WO PCT/NL2007/050059 patent/WO2007094665A1/en active Application Filing
• 2010
  • 2010-09-30 US US12/895,768 patent/US20110021733A1/en not_active Abandoned

Patent Citations (4)

Also Published As

Similar Documents

Legal Events